Buckingham Capital Management (New York)’s Collegium Pharmaceutical COLL Stock Holding History

Buckingham Capital Management (New York)’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-513,759	Closed	-$5.39M	–	97
2017 Q3	$5.39M	Sell	513,759 -105,646	-17%	-$1.16M	0.71%	53
2017 Q2	$7.75M	Buy	619,405 +232,727	+60%	+$2.3M	0.91%	51
2017 Q1	$3.89M	Buy	386,678 +55,800	+17%	+$829K	0.52%	66
2016 Q4	$5.15M	Buy	330,878 +277,578	+521%	+$4.61M	0.68%	58
2016 Q3	$1.03M	Buy	+53,300	New	+$633K	0.13%	86

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Buckingham Capital Management (New York)'s COLL Position: Q4 2017 in Review

Buckingham Capital Management (New York) sold out of Collegium Pharmaceutical (COLL) in Q4 2017, closing a stake of 513,759 shares — an estimated $5.39M sold.

Buckingham Capital Management (New York) first reported a position in COLL in Q3 2016 and held it in 5 quarters. The position peaked at $7.75M in Q2 2017. 101 funds tracked by Wall St. Rank hold COLL as of Q4 2017.

Buckingham Capital Management (New York) reported no remaining Collegium Pharmaceutical position as of Q4 2017 after selling out during the quarter.
Buckingham Capital Management (New York) sold 513,759 Collegium Pharmaceutical shares in Q4 2017, an estimated $5.39M.
Buckingham Capital Management (New York) first reported a position in Collegium Pharmaceutical in Q3 2016 and held it in 5 quarters.
Buckingham Capital Management (New York)'s Collegium Pharmaceutical position peaked at $7.75M in Q2 2017.
101 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2017.

Based on Buckingham Capital Management (New York)'s 13F filing for Q4 2017, filed 8 Feb 2018.